BDTX - Black Diamond Therapeutics, Inc.
2.7
-0.220 -8.148%
Share volume: 695,233
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$2.92
-0.22
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-05-2024 | 03-06-2025 | 05-12-2025 | 11-06-2025 | 03-16-2026 | |
| Cash flow financing | 4.130 M | 21.378 M | -252.000 K | 291.000 K | 32.000 K | 134.000 K | -196.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 134.000 K | -196.000 K | |
| Cash flow | -30.803 M | 7.392 M | -9.382 M | 13.005 M | 61.989 M | 874.000 K | -9.872 M | |
| Net income | -18.225 M | -19.909 M | -15.557 M | -15.985 M | 56.542 M | -8.498 M | -15.116 M | |
| Depreciation | 86.000 K | 86.000 K | 86.000 K | 85.000 K | 87.000 K | 86.000 K | 66.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -13.734 M | 740.000 K | 2.193 M | 27.769 M | 8.547 M | 8.590 M | -2.889 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | -48.000 K | -8.000 K | -13.000 K | -1.000 K | -3.000 K | |
| Cash Change | -30.803 M | 7.392 M | -9.382 M | 13.005 M | 61.989 M | 874.000 K | -9.872 M |